At a Glance
- Identification of novel cancer genetic risk factors and diagnosis markers.
- Dissect the cancer cell signaling mechanisms.
- Multidisciplinary approach to cancer research.
- Integration of multiomics, CRISPR-Cas9 screening, biochemistry, and molecular biology
- Focus on discovering novel therapeutic options for patients with high-risk cancers
Dr. Hakem is a Professor at the Department of Medical Biophysics at the University of Toronto. He is also a Senior Scientist at the Princess Margaret Cancer Centre. He received his Ph.D from the University of Aix-Marseille II, France. He completed his post-doctoral training at the Howard Hughes Medical Institute / Washington University Medical School, Saint Louis in the US and the Amgen Research Institute in Toronto. Dr. Hakem started his faculty position in 1998 and has focused his research program on identification of cancer mechanisms and discovering better therapeutic strategies for cancer.
Dr. Hakem’s laboratory has identified several novel tumor suppressor genes and extensively investigated their functions and how their loss or mutations promote cancer development. Dr. Hakem is a world-class expert in cancer genetics, cell signaling, and molecular oncology. His work has been published in leading journals including Cell, Science, Nature Genetics, Nature Communications, and The Journal of Clinical Investigation.
Dr. Hakem is well funded, and he is committed to providing excellent supervision and training to his students to allow them to be the next generation of Scientists. Several former trainees in the Hakem lab are now faculty members in top universities or have influential positions in the private sector.
Dr. Hakem is interested in supervising students who are highly self-motivated, interested in making discoveries, and committed to cancer research to help patients.